1. C/EBPβ expression decreases in cervical cancer and leads to tumorigenesis
    Haichen Long et al, 2023, BMC Cancer CrossRef
  2. AdipoRon: A Novel Insulin Sensitizer in Various Complications and the Underlying Mechanisms: A Review
    Ishfaq Ahmad Bhat et al, 2020, Current Molecular Pharmacology CrossRef
  3. The adiponectin signalling pathway - A therapeutic target for the cardiac complications of type 2 diabetes?
    Abhipree Sharma et al, 2022, Pharmacology & Therapeutics CrossRef
  4. Antiobesity Drug Discovery Research: In vitro Models for Shortening the Drug Discovery Pipeline
    null Radheshyam et al, 2024, Current Drug Targets CrossRef
  5. Potential Role of Adiponectin Receptor Agonist, AdipoRon in Cardiometabolic Disease
    Eunhee Cho et al, 2019, Exercise Science CrossRef
  6. AdipoRon Treatment Induces a Dose-Dependent Response in Adult Hippocampal Neurogenesis
    Thomas H. Lee et al, 2021, International Journal of Molecular Sciences CrossRef
  7. An adiponectin receptor agonist promote osteogenesis via regulating bone‐fat balance
    Hanghang Liu et al, 2021, Cell Proliferation CrossRef

  8. Inhibition of CSRP2 Promotes Leukemia Cell Proliferation and Correlates with Relapse in Adults with Acute Myeloid Leukemia


    Shujuan Wang et al, 2020, OncoTargets and Therapy CrossRef
  9. The impact of adipokines on vascular networks in adipose tissue
    Maria Vliora et al, 2023, Cytokine & Growth Factor Reviews CrossRef
  10. S100A16suppresses the growth and survival of leukaemia cells and correlates with relapse and relapse free survival in adults with Philadelphia chromosome‐negative B‐cell acute lymphoblastic leukaemia
    Jing Zhang et al, 2019, British Journal of Haematology CrossRef
  11. AMPK activation inhibits the functions of myeloid-derived suppressor cells (MDSC): impact on cancer and aging
    Antero Salminen et al, 2019, Journal of Molecular Medicine CrossRef
  12. Murine in vitro cellular models to better understand adipogenesis and its potential applications
    Muhammad Sufyan Vohra et al, 2020, Differentiation CrossRef
  13. Diacerein versus adipoRon as adiponectin modulators in experimentally-induced end-stage type 2 diabetes mellitus in rats
    Mahmoud M. Samaha et al, 2022, Environmental Toxicology and Pharmacology CrossRef
  14. The adiponectin agonist, AdipoRon, inhibits steroidogenesis and cell proliferation in human luteinized granulosa cells
    Jérémy Grandhaye et al, 2021, Molecular and Cellular Endocrinology CrossRef
  15. Potential Adiponectin Receptor Response Modifier Therapeutics
    Laszlo Otvos, 2019, Frontiers in Endocrinology CrossRef
  16. AdipoRon, a new therapeutic prospect for Duchenne muscular dystrophy
    Michel Abou‐Samra et al, 2020, Journal of Cachexia, Sarcopenia and Muscle CrossRef